High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence.

A mutant of bovine pancreatic trypsin inhibitor (BPTI) has been constructed and expressed in Escherichia coli in order to probe the kinetic and structural consequences of truncating the binding loop residues to alanine. In addition to two such mutations (Thr11Ala and Pro13Ala), it has a conservative Lys15Arg substitution at position P(1) and an unrelated Met52Leu change. In spite of the binding loop modification, the affinity for trypsin is only 30 times lower than that of the wild-type protein. At pH 7.5 the protein can be crystallized on the time-scale of hours, yielding very stable crystals of a new (tetragonal) form of BPTI. Conventional source X-ray data collected to 1.4 A at room temperature allowed anisotropic structure refinement characterized by R=0.1048. The structure reveals all 58 residues, including the complete C terminus, which is in a salt-bridge contact with the N terminus. The Cys14-Cys38 disulfide bridge is observed in two distinct chiralities. This bridge, together with an internal water molecule, contributes to the stabilization of the binding loop. The Ala mutations have only an insignificant and localized effect on the binding loop, which retains its wild-type conformation (maximum deviation of loop C(alpha) atoms of 0.7 A at Ala13). Four (instead of the typical three) additional water molecules are buried in an internal cleft and connected to the surface via a sulfate anion. Three more SO(4)(2-) anions are seen in the electron density, one of them located on a 2-fold axis. It participates in the formation of a dimeric structure between symmetry-related BPTI molecules, in which electrostatic and hydrogen bonding interactions resulting from the mutated Lys15Arg substitution are of central importance. This dimeric interaction involves direct recognition loop-recognition loop contacts, part of which are hydrophobic interactions of the patches created by the alanine mutations. Another 2-fold symmetric interaction between the BPTI molecules involves the formation of an antiparallel intermolecular beta-sheet that, together with the adjacent intramolecular beta-hairpin loops, creates a four-stranded structure.

[1]  A. Kossiakoff,et al.  Structural effects induced by mutagenesis affected by crystal packing factors: The structure of a 30–51 disulfide mutant of basic pancreatic trypsin inhibitor , 1992, Proteins.

[2]  W. Bode,et al.  Refined 2.5 A X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor. Crystallization, Patterson search, structure determination, refinement, structure and comparison with its components and with the bovine trypsin-pancreatic trypsin inhibit , 1983, Journal of molecular biology.

[3]  V. Luzzati,et al.  Traitement statistique des erreurs dans la determination des structures cristallines , 1952 .

[4]  S. Zinn-Justin,et al.  Conformational and functional variability supported by the BPTI fold: Solution structure of the Ca2+ channel blocker calcicludine , 1999, Proteins.

[5]  M. Sundaralingam,et al.  Hydration of Protein Secondary Structures—The Role in Protein Folding , 1993 .

[6]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[7]  R. Huber,et al.  The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa. , 1997, Journal of molecular biology.

[8]  G. Sheldrick,et al.  SHELXL: high-resolution refinement. , 1997, Methods in enzymology.

[9]  T. Prangé,et al.  The decameric structure of bovine pancreatic trypsin inhibitor (BPTI) crystallized from thiocyanate at 2.7 A resolution. , 1999, Acta Crystallographica Section D: Biological Crystallography.

[10]  J Otlewski,et al.  Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases. , 1999, Journal of molecular biology.

[11]  G. N. Ramachandran,et al.  Stereochemistry of polypeptide chain configurations. , 1963, Journal of molecular biology.

[12]  T A Jones,et al.  Errors and reproducibility in electron-density map interpretation. , 1999, Acta crystallographica. Section D, Biological crystallography.

[13]  Y. Satow,et al.  Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. , 1985, Journal of molecular biology.

[14]  D. Ollis,et al.  The crystal structure of bikunin from the inter-alpha-inhibitor complex: a serine protease inhibitor with two Kunitz domains. , 1998, Journal of molecular biology.

[15]  Wolfgang Kabsch,et al.  Evaluation of Single-Crystal X-ray Diffraction Data from a Position-Sensitive Detector , 1988 .

[16]  K. Wilson,et al.  Efficient anisotropic refinement of macromolecular structures using FFT. , 1999, Acta crystallographica. Section D, Biological crystallography.

[17]  S. Anderson,et al.  Alanine Point-Mutations in the Reactive Region of Bovine Pancreatic Trypsin Inhibitor: Effects on the Kinetics and Thermodynamics of Binding to β-Trypsin and α-Chymotrypsin† , 1996 .

[18]  B. Matthews Solvent content of protein crystals. , 1968, Journal of molecular biology.

[19]  Crevice‐forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: Crystal structures of F22A, Y23A, N43G, and F45A , 1993, Protein science : a publication of the Protein Society.

[20]  C. Woodward,et al.  Structure of form III crystals of bovine pancreatic trypsin inhibitor. , 1987, Journal of molecular biology.

[21]  Robert Huber,et al.  Structure of bovine pancreatic trypsin inhibitor , 1984 .

[22]  T. Skarzynski,et al.  Crystal structure of α-dendrotoxin from the green mamba venom and its comparison with the structure of bovine pancreatic trypsin inhibitor , 1992 .

[23]  K. Wüthrich,et al.  Disulfide bond isomerization in BPTI and BPTI(G36S): an NMR study of correlated mobility in proteins. , 1993, Biochemistry.

[24]  R. Timpl,et al.  Structure and multiple conformations of the kunitz-type domain from human type VI collagen alpha3(VI) chain in solution. , 1996, Structure.

[25]  R. Huber,et al.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. , 1973, Journal of molecular biology.

[26]  D. Marion,et al.  Proteinase inhibitor homologues as potassium channel blockers , 1994, Nature Structural Biology.

[27]  J. Richardson,et al.  The anatomy and taxonomy of protein structure. , 1981, Advances in protein chemistry.

[28]  R. Kretsinger,et al.  Refinement of the structure of carp muscle calcium-binding parvalbumin by model building and difference Fourier analysis. , 1976, Journal of molecular biology.

[29]  G. Otting,et al.  Studies of protein hydration in aqueous solution by direct NMR observation of individual protein-bound water molecules , 1989 .

[30]  Sung-Hou Kim,et al.  Sparse matrix sampling: a screening method for crystallization of proteins , 1991 .

[31]  A Wlodawer,et al.  Crystal structure of a Y35G mutant of bovine pancreatic trypsin inhibitor. , 1991, Journal of molecular biology.

[32]  J. Otlewski,et al.  Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin. , 1998, Journal of molecular biology.

[33]  K Wüthrich,et al.  Protein hydration in aqueous solution. , 1991, Science.

[34]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[35]  R. Huber,et al.  The thrombin E192Q–BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin , 1997, The EMBO journal.

[36]  B. Rupp,et al.  Structure of bovine pancreatic trypsin inhibitor at 125 K definition of carboxyl-terminal residues Gly57 and Ala58. , 1996, Acta crystallographica. Section D, Biological crystallography.

[37]  T. Hynes,et al.  X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor. , 1990, Biochemistry.

[38]  H. Fritz,et al.  Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. , 1983, Arzneimittel-Forschung.

[39]  Decamers observed in the crystals of bovine pancreatic trypsin inhibitor. , 1999, Acta crystallographica. Section D, Biological crystallography.

[40]  R. Huber,et al.  The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. , 1975, Biochemistry.

[41]  K Wüthrich,et al.  Determination of a high-quality nuclear magnetic resonance solution structure of the bovine pancreatic trypsin inhibitor and comparison with three crystal structures. , 1992, Journal of molecular biology.

[42]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[43]  R. Huber,et al.  The ornithodorin‐thrombin crystal structure, a key to the TAP enigma? , 1996, The EMBO journal.

[44]  K Wüthrich,et al.  NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata , 1994, FEBS letters.

[45]  A. Ducruix,et al.  1.2 A refinement of the Kunitz-type domain from the alpha3 chain of human type VI collagen. , 1998, Acta crystallographica. Section D, Biological crystallography.

[46]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[47]  R. St Charles,et al.  Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. , 1999, Journal of molecular biology.

[48]  R. Huber,et al.  Natural protein proteinase inhibitors and their interaction with proteinases. , 1992, European journal of biochemistry.

[49]  J Deisenhofer,et al.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. , 1974, Journal of molecular biology.

[50]  J. Deisenhofer,et al.  Crystallographic refinement of the structure of bovine pancreatic trypsin inhibitor at l.5 Å resolution , 1975 .

[51]  R. Huber,et al.  Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement , 1991 .

[52]  T. Hynes,et al.  Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of alzheimer's amyloid β‐protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): Engineering of inhibitors with altered specificities , 1997, Protein science : a publication of the Protein Society.

[53]  NMR structure determination of tick anticoagulant peptide (TAP) , 1995, Protein science : a publication of the Protein Society.

[54]  G. Mocz Fuzzy cluster analysis of simple physicochemical properties of amino acids for recognizing secondary structure in proteins , 1995, Protein science : a publication of the Protein Society.

[55]  F. Studier,et al.  Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.

[56]  J. Otlewski,et al.  Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins , 1998, Proteins.

[57]  P. Sigler,et al.  Structure of beta 2-bungarotoxin: potassium channel binding by Kunitz modules and targeted phospholipase action. , 1995, Structure.

[58]  P. Butterworth Topics in molecular and structural biology , 1994 .